Medexter CEO Begins New Term as Co-Chair of HL7 International’s Arden Syntax Work Group

Medexter is pleased to announce that its CEO, Klaus-Peter Adlassnig, will begin a new two-year term as Co-Chair of HL7 International’s Arden Syntax Work Group in January 2026.

HL7 International is an ANSI-accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information worldwide.

Together with his fellow Co-Chair, Robert Jenders, Klaus-Peter Adlassnig will continue to lead the evolution of the Arden Syntax standard, focusing on ongoing improvements, new features, and continued alignment with FHIR. This work reflects Medexter’s ongoing commitment to international standards development and to advancing interoperable, data-driven healthcare.